{"id":"W2550252965","doi":"10.1136/annrheumdis-2016-eular.2306","title":"SAT0396 Secukinumab Provides Sustained Improvements in The Signs and Symptoms of Active Ankylosing Spondylitis: 2-Year Results from A Phase 3 Trial with Subcutaneous Loading and Maintenance Dosing (Measure 2)","year":2016,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Secukinumab; Ankylosing spondylitis; Clinical endpoint; Placebo; Internal medicine; Dosing; Gastroenterology; Clinical trial; Psoriatic arthritis; Rheumatoid arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002038615,0.001793867,0.002726436,0.0005735497,0.0004782651,0.001463398,0.0009450062,0.001447266,0.003367632],"category_scores_gemma":[0.0009079112,0.0005758099,0.003222748,0.0004898625,0.001099731,0.001376641,0.0003701125,0.003906716,0.0009397133],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006425012,"about_ca_system_score_gemma":0.0008074963,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001068152,"about_ca_topic_score_gemma":0.002129687,"domain_scores_codex":[0.9993161,0.0002262524,0.00005404737,0.0001048654,0.0001025517,0.0001961645],"domain_scores_gemma":[0.9992836,0.0001413279,0.0001704094,0.00008846333,0.00005876647,0.0002574541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8037153,0.03478076,0.004033116,0.0007812808,0.002965262,0.0002292329,0.0002605046,0.001470428,0.02980317,0.0001578817,0.00287033,0.1189328],"study_design_scores_gemma":[0.4729173,0.5001805,0.0191168,0.00004285898,0.0008832634,0.000294364,0.0000940649,0.0009018437,0.004343158,0.0001234125,0.001047165,0.00005520012],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948802,0.002383603,0.0003067072,0.0003162126,0.0001341444,0.0003644866,0.0006746608,0.0001403058,0.0007996117],"genre_scores_gemma":[0.9930732,0.001665615,0.0008903895,0.0006837653,0.0002026935,0.0004705278,0.001459189,0.00003298695,0.001521659],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003367632,"threshold_uncertainty_score":0.01126587,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02175200855632477,"score_gpt":0.2843987641834563,"score_spread":0.2626467556271316,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}